Tuesdays with Mary: DNA
Tuesday, May 7, 2024 I’ve been thinking about your DNA, and mine too. Something might have missed last October is the direct-to-consumer genomic testing company 23andMe fell victim to a cyber-attack. It’s also true that the company once valued at $6 billion is now valued at roughly $0. Those things are both related and unrelated, but it’s an interesting story. In case you aren’t entirely familiar, 23andMe set out to solve a problem. The problem, as they saw it, was that genetic testing is not yet routinely used to understand potential health futures for most Americans. They believed our health [...]